Feriandas Greblikas Selected Research

fosmetpantotenate

1/2021	Fosmetpantotenate Randomized Controlled Trial in Pantothenate Kinase-Associated Neurodegeneration.
1/2019	The FOsmetpantotenate Replacement Therapy (FORT) randomized, double-blind, Placebo-controlled pivotal trial: Study design and development methodology of a novel primary efficacy outcome in patients with pantothenate kinase-associated neurodegeneration.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Feriandas Greblikas Research Topics

Disease

2	Pantothenate Kinase-Associated Neurodegeneration (Hallervorden-Spatz Disease) 01/2021 - 01/2019
1	Disease Progression 01/2021

Drug/Important Bio-Agent (IBA)

2	fosmetpantotenateIBA 01/2021 - 01/2019
1	Pharmaceutical PreparationsIBA 01/2019

Therapy/Procedure

2	Therapeutics 01/2021 - 01/2019
1	Activities of Daily Living (ADL) 01/2019